Alteration of cell cycle in cervical tumor associated with human papillomavirus - Cyclin-dependent kinase inhibitors

Yonsei Medical Journal

Volumn 43, Issue 6, 2002, Pages 722-728

  Cho, Nam Hoo ^a   Kim, Young Tae ^a   Kim, Jae Wook ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Cervix cancer; Cyclin dependent kinase; Human papillomavirus

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYCLINE; PROTEIN P16; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; VIRUS PROTEIN;

BINDING SITE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; GENETIC STABILITY; HUMAN; HUMAN CELL; MITOSIS; MITOSIS SPINDLE; MOLECULAR GENETICS; PROGNOSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; TUMOR SUPPRESSOR GENE; UTERINE CERVIX TUMOR; WART VIRUS;

EID: 0036957236     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2002.43.6.722     Document Type: Review

References (35)

1. Sherr CJ. The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res 2000;60:3689-95.
2. Palazzo JP. Cyclin-dependent kinase inhibitors-a novel class of prognostic indicators. Hum Pathol 2001;32:769-70.
3. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 1994;78:67-74.
4. Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000;183:10-7.
5. Sgambato A, Cittadini A, Faraglia B, Weinstein B. Multiple functions of p27 and its alteration in tumor cells: A review. J Cell Physiol 2000;183:18-27.
6. Parker SB, Eichele G, Zhang P, Rawis A, Sands AT, Bradley A, et al. p53-independent expression of p21 in muscle and other terminally differentiating cells. Science 1995;267:1024-7.
7. Loda M, Cukor B, Tam SW. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997;3:231-4.
8. Thompson DA, Belinsky G, Chang TH, Jones DL, Schlegel R, Munger K. The human papillomavirus-16 E6 oncoprotein decrease the vigilance of mitotic checkpoints. Oncogene 1997;15:3025-35.
9. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996;1288: 55-78.
10. Chang T, Ray F, Thompson D, Schlegel R. Disregulation of mitotic checkpoints and regulatory proteins following acute expression of SV40 large T antigen in diploid human cells. Oncogene 1997;14:2383-94.
11. Aloni-Grinstein R, Schwartz D, Rotter V. Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression. EMBO J 1995;14:1392-401.
12. Morgan DO. Principles of CDK regulation. Nature 1995;374:131-4.
13. El-Deiry WS, Tokino VE, Velculescu DB, Levy R, Parsons JM, Trent D, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
14. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SI. The p21 cdk-interacting protein Cip 1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75: 805-16.
15. Xiong Y, Hannon GJ, Zhang D, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-4.
16. Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev 1997;11:2090-100.
17. Serrano M. The tumor suppressor protein p16 INK4a. Exp Cell Res 1997;237:7-13.
18. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996;16:859-67.
19. Palmero I, McConnell B, Parry D, Brookes S, Hara E, Bates S, et al. Accumulation of p16 INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblatoma gene status. Oncogene 1997;15: 495-503
20. Xiong Y, Zhang H, Beach D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 1993;7:1572-83.
21. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4 Nature 1993;366:704-7.
22. Xiong Y, Kuppuswamy D, Li Y, Livanos E, Hixon M, White M, et al. Alteration of cell cycle complexes in human pappilomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation. J Virol 1996; 70:999-1008
23. Soucek T, Pusch O, Hengastchlager-Ottnad E, Wawra E, Bernaaschek G, Hengstschlager M. Expression of the cyclin-dependent kinase inhibitor p16 during the ongoing cell cycle. FEBS Lett 1995;373:164-9.
24. Kim YT, Cho NH, Park SW, Kim JW. Underexpression of cyclin-dependent kinase inhibitors in cervical carcinoma. Gynecol Oncol 1998;71:38-45.
25. Koff A, Ohtshki M, Polyak K, Roberts JM, Massague J. Negative regulation of G1 in mammlian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 1993; 260:536-9.
26. Hengst L, Dulic V, Slingerland J, Lees E, Reed SL A cell cycle regulated inhibitor of cyclin dependent kinases. Proc Natl Acad Sci USA 1994;91:5291-4.
27. Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000;183:10-7.
28. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, et al. Role of ubiquitin-proteaome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995;269:682-5.
29. Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Rotz JW, Jansen-Durr P. Inactivation of the cdk inhibitor p27KIP1 by the human pappilomavirus 16 E7 oncoprotein. Oncogene 1996;13:2323-30.
30. Kim YT, Choi EK, Cho NH, Ko JH, Yang WI, Kim JW, et al. Expression of cyclin E and p27 in cervical carcinoma. Cancer Lett 2000;153:41-50.
31. Cho NH, Kim YT, Kim JW. Correlation between G1 cyclins and HPV in the uterine cervix. Int J Gynecol Pathol 1997;16:340-7.
32. Jonczyk P, White A, Lum K, Barrrett JC, Tlsty TD. Amplification potential in prenoplastic and neoplastic Syrian hamster embryo fibroblasts transformed by various carcinogens. Cancer Res 1992;53:3098-102.
33. Wang W, Caldwell MC, Lin S, Furneaux H, Gorospe M. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 2000;19:2340-50.
34. Cho NH, Lim SY, Kim YT, Kim DK, Kim YS, Kim JW. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value. Gynecol Oncol 2002 [In Press].
35. cdc2 protein kinase during mitosis. Cell 1989;58:361-72.